The application of bone marrow transplantation to the treatment of genetic diseases
- PMID: 3520819
- DOI: 10.1126/science.3520819
The application of bone marrow transplantation to the treatment of genetic diseases
Abstract
Genetic diseases can be treated by transplantation of either normal allogeneic bone marrow or, potentially, autologous bone marrow into which the normal gene has been inserted in vitro (gene therapy). Histocompatible allogeneic bone marrow transplantation is used for the treatment of genetic diseases whose clinical expression is restricted to lymphoid or hematopoietic cells. The therapeutic role of bone marrow transplantation in the treatment of generalized genetic diseases, especially those affecting the central nervous system, is under investigation. The response of a generalized genetic disease to allogeneic bone marrow transplantation may be predicted by experiments in vitro. Gene therapy can be used only when the gene responsible for the disease has been characterized. Success of gene therapy for a specific genetic disease may be predicted by its clinical response to allogeneic bone marrow transplantation.
Similar articles
-
[Correction of fatal genetic diseases using bone marrow transplantation. 1].Kinderarztl Prax. 1991 Jan-Feb;59(1-2):6-9. Kinderarztl Prax. 1991. PMID: 2056664 Review. German.
-
Somatic gene therapy. Current status and future prospects.J Clin Invest. 1986 Apr;77(4):1053-6. doi: 10.1172/JCI112403. J Clin Invest. 1986. PMID: 3514670 Free PMC article. No abstract available.
-
Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Marrow Transplantation (EBMT).Bone Marrow Transplant. 1997 Mar;19(5):407-19. doi: 10.1038/sj.bmt.1700694. Bone Marrow Transplant. 1997. PMID: 9052905
-
Prospects for gene therapy of human disease.Allergol Immunopathol (Madr). 1991 Jan-Feb;19(1):25-8. Allergol Immunopathol (Madr). 1991. PMID: 1683140 Review. No abstract available.
-
The role of non-myeloablative conditioning in allowing engraftment of allogeneic hematopoietic cells for correction of genetic disorders and for immunotherapy of leukemia.Ann Transplant. 2001;6(1):9-13. Ann Transplant. 2001. PMID: 11803609 Review.
Cited by
-
Prospect for enzyme therapy in glycogenosis II variants: a study on cultured muscle cells.J Neurol. 1988 Sep;235(7):392-6. doi: 10.1007/BF00314479. J Neurol. 1988. PMID: 3065462
-
Analysis of graft-versus-host disease (GVHD) and graft rejection using MHC class I-deficient mice.Clin Exp Immunol. 1998 May;112(2):188-95. doi: 10.1046/j.1365-2249.1998.00578.x. Clin Exp Immunol. 1998. PMID: 9649180 Free PMC article.
-
Bone marrow transplantation. Part I--Allogeneic.West J Med. 1989 Dec;151(6):638-43. West J Med. 1989. PMID: 2694621 Free PMC article. Review.
-
Cellular transplants.Transplant Proc. 1991 Feb;23(1 Pt 1):73-6. Transplant Proc. 1991. PMID: 1990667 Free PMC article. Review. No abstract available.
-
Retroviral gene transfer into primary hepatocytes: implications for genetic therapy of liver-specific functions.Proc Natl Acad Sci U S A. 1987 Aug;84(15):5335-9. doi: 10.1073/pnas.84.15.5335. Proc Natl Acad Sci U S A. 1987. PMID: 3474659 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical